- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
+0.21| Last Update: 05/24/13 - 4:00 PM EDT |
| Volume: 276,849 |
| YTD Performance: -9.54% |
| Open: $47.43 |
| Previous Close: $47.52 |
| 52 Week Range: $37.11 - $56.73 |
| Oustanding Shares: 27,635,851 |
| Market Cap: 1,313,255,640 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (04/13) | Qtr (07/13) | FY (04/13) | FY (04/14) | |
|---|---|---|---|---|
| Average Estimate | $0.42 | $0.45 | $1.70 | $1.93 |
| Number of Analysts | 5 | 5 | 6 | 5 |
| High Estimate | $0.45 | $0.46 | $1.73 | $2.03 |
| Low Estimate | $0.40 | $0.43 | $1.68 | $1.83 |
| Prior Year | $0.38 | $0.38 | $1.27 | $1.70 |
| Growth Rate (Year over Year) | 11.58% | 17.89% | 33.99% | 13.18% |
Cyberonics upgraded at LazardCYBX was upgraded to Buy, Lazard Capital Market said. A proprietary survey showed that sales reps were not using inappropriate sales tactics, making the recent pullback a buying opportunity. Estimates through 2014 were raised, $57 price target.
Cyberonics numbers raised at CanaccordShares of CYBX now seen reaching $57, Canaccord said. Estimates also raised on a record quarter. Buy rating.
Cyberonics upgraded at Canaccord CYBX was upgraded from Hold to Buy, Canaccord Genuity said. $56 price target. Company continues to execute well and depression treatment should drive near-term growth.
I’m making trades in Movado and Sanderson Farms but passing on Cyberonics and PVH.
There are four reports coming up I find interesting.
Contributor Ken Shreve takes a look at upcoming economic data and some key earnings reports for the week of Aug. 27
These promising medical-device names aren’t on the S&P, but they deserve plenty of attention.
Cyberonics numbers raised at JefferiesShares of CYBX now seen reaching $58, Jefferies said. Estimates also raised on Chance of reversing coverage policy. Buy rating.
Contributor Ken Shreve takes a look at a light week of economic data and some earnings reports for the week of June 4